Your browser doesn't support javascript.
loading
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
Yoshiji, H; Kuriyama, S; Kawata, M; Yoshii, J; Ikenaka, Y; Noguchi, R; Nakatani, T; Tsujinoue, H; Fukui, H.
Affiliation
  • Yoshiji H; Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara Nara 634-8522, Japan. yoshijih@naramed-u.ac.jp
Clin Cancer Res ; 7(4): 1073-8, 2001 Apr.
Article in En | MEDLINE | ID: mdl-11309359
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Endothelial Growth Factors / Lymphokines / Perindopril / Neoplasms / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Endothelial Growth Factors / Lymphokines / Perindopril / Neoplasms / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Country of publication: